Recombinant Human SUMO3 Protein，His

SUMO3 (Small Ubiquitin-like Modifier 3) is a member of the SUMO (Small Ubiquitin-like Modifier) protein family, which plays a crucial role in post-translational modifications influencing various cellular processes, including protein stability, localization, and activity. The study of SUMO3 is particularly significant due to its involvement in several critical biological functions, such as cell cycle regulation, DNA repair, and stress response, which are essential in maintaining cellular homeostasis. Abnormal SUMOylation, the process by which SUMO proteins are conjugated to target proteins, has been implicated in various diseases, including cancer, neurodegenerative disorders, and inflammatory diseases. Research on SUMO3 has gained momentum in recent years as scientists aim to unravel its specific roles and mechanisms within cellular pathways. Understanding how SUMO3 interacts with other proteins and pathways can provide insights into its potential as a therapeutic target. Advances in techniques such as proteomics and structural biology have facilitated the investigation of SUMO3’s structure-function relationship and its dynamics within the SUMOylation pathway. This knowledge not only contributes to a deeper comprehension of SUMO3's biological significance but also enhances our understanding of the wider implications of SUMOylation in health and disease. Consequently, ongoing studies focus on elucidating the regulatory networks involving SUMO3, aiming to identify novel modulators or inhibitors that could be leveraged for therapeutic applications, paving the way for innovative strategies in treating SUMO-related diseases.